Investor relations
Abingdon Health plc (AIM: ABDX | OTCQB: ABDXF). Key financial information, regulatory announcements and corporate governance for shareholders and analysts.
Investor relations
Information for shareholders and analysts
Abingdon Health plc is listed on AIM, the London Stock Exchange's growth market, under the ticker ABDX.
Click each section below to find the information you need.
Board and governance
Meet the board of directors, review committee structures and corporate governance framework.
AIM Rule 26
Company information required under AIM Rule 26 including constitution, shares in issue and significant shareholders.
Documents and reports
Annual reports, interim accounts, AGM notices and investor presentations.
Regulatory announcements
RNS announcements and regulatory news service feed via the London Stock Exchange.
Latest news
Trading updates, results and company news for investors.
Investor meetings
Upcoming live investor presentations and on-demand recordings of past meetings.
Research
Independent analyst research and notes on Abingdon Health plc.
Shareholder Market Data
Live share price, market data, historical chart, shares in issue and major shareholders.
Investor contacts
Contact details for investor enquiries, our nominated adviser and professional advisers.
At a glance
Abingdon Health plc
AIM and OTCQB listed
Listed on the AIM market of the London Stock Exchange (ABDX) and traded on the OTCQB Venture Market in the US (ABDXF), providing investors with a regulated and transparent trading environment.
Global presence
Headquartered in York, UK, with an independent analytical test house in Doncaster and a full development laboratory and manufacturing facility in Madison, Wisconsin, USA.
Full service CDMO
End-to-end lateral flow development and manufacturing, from concept through regulatory approval to large-scale commercial production.
Growing market
Positioned in the rapidly expanding point-of-care diagnostics and MedTech sectors, serving a wide range of industries globally.
Questions for the investor relations team?
Contact us for shareholder information, financial reports or governance enquiries.